Company Profile · Healthcare

Jafron Biomedical Co Ltd

300529 · Shenzhen

Country: China
Employees: 2,200
Website: www.jafroninternational.com

Buffett Score

84/100

Elite

Financial snapshot

Market capCN¥12.19B

Revenue (TTM)CN¥1.91B

EBITDACN¥793.28M

Profit margin27.49%

ROE15.98%

P/E (TTM)22.79

Forward P/E0

EPSCN¥0.67

Dividend yield3.48%

52-week rangeCN¥14.73 – CN¥21.65

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

About the company

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Background

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

Research on this stock

No reports on this stock in your language yet.